---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-063565"
form_type: "8-K"
ticker: "TMCI"
cik: "0001630627"
company_name: "TREACE MEDICAL CONCEPTS, INC."
filed_at: "2024-05-22T23:59:59+00:00"
generated_at: "2026-06-01T09:46:00.764676+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# TMCI stockholders re-elect directors and approve executive compensation at 2024 annual meeting

## Summary
- Elected John K. Bakewell (39.1M for), Richard W. Mott (40.2M for), John T. Treace (44.0M for) as Class III directors.
- Advisory vote on executive compensation approved: 44.8M for, 4.0M against, 13.9K abstain.
- Stockholders favored holding Say-on-Pay vote every 1 year (46.7M votes); board adopted annual frequency.
- Ratified Grant Thornton as independent auditor for FY2024: 52.7M for, 2.1M against, 2.6K abstain.

## SEC filing metadata
- accession: 0000950170-24-063565
- form_type: 8-K
- ticker: TMCI
- cik: 0001630627
- company_name: TREACE MEDICAL CONCEPTS, INC.
- filed_at: 2024-05-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1630627/000095017024063565/0000950170-24-063565-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1630627/000095017024063565/tmci-20240521.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-063565
- JSON: https://secwatch.observer/filing/0000950170-24-063565.json
- Plain text: https://secwatch.observer/filing/0000950170-24-063565.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.